Literature DB >> 25171465

Improvement in bronchiectasis on CT imaging in a pediatric patient with cystic fibrosis on ivacaftor therapy.

Don Hayes1, Frederick R Long, Karen S McCoy, Shahid I Sheikh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25171465     DOI: 10.1159/000365999

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


× No keyword cloud information.
  4 in total

1.  PharmGKB summary: very important pharmacogene information for CFTR.

Authors:  Ellen M McDonagh; John P Clancy; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-03       Impact factor: 2.089

Review 2.  New and emerging targeted therapies for cystic fibrosis.

Authors:  Bradley S Quon; Steven M Rowe
Journal:  BMJ       Date:  2016-03-30

Review 3.  Toward inclusive therapy with CFTR modulators: Progress and challenges.

Authors:  Jennifer Guimbellot; Jyoti Sharma; Steven M Rowe
Journal:  Pediatr Pulmonol       Date:  2017-09-07

Review 4.  Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.

Authors:  Marcus A Mall; Nicole Mayer-Hamblett; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.